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Abstract
Background: Extensive alveolar epithelial injury and remodelling is a common feature of acute lung injury and
acute respiratory distress syndrome (ARDS) and it has been established that epithelial regeneration, and secondary
lung oedema resorption, is crucial for ARDS resolution. Much evidence indicates that K+ channels are regulating
epithelial repair processes; however, involvement of the KCa3.1 channels in alveolar repair has never been
investigated before.
Results: Wound-healing assays demonstrated that the repair rates were increased in primary rat alveolar cell
monolayers grown on a fibronectin matrix compared to non-coated supports, whereas an anti-β1-integrin antibody
reduced it. KCa3.1 inhibition/silencing impaired the fibronectin-stimulated wound-healing rates, as well as cell
migration and proliferation, but had no effect in the absence of coating. We then evaluated a putative relationship
between KCa3.1 channel and the migratory machinery protein β1-integrin, which is activated by fibronectin.
Co-immunoprecipitation and immunofluorescence experiments indicated a link between the two proteins and
revealed their cellular co-distribution. In addition, we demonstrated that KCa3.1 channel and β1-integrin membrane
expressions were increased on a fibronectin matrix. We also showed increased intracellular calcium concentrations
as well as enhanced expression of TRPC4, a voltage-independent calcium channel belonging to the large TRP
channel family, on a fibronectin matrix. Finally, wound-healing assays showed additive effects of KCa3.1 and TRPC4
inhibitors on alveolar epithelial repair.
Conclusion: Taken together, our data demonstrate for the first time complementary roles of KCa3.1 and TRPC4
channels with extracellular matrix and β1-integrin in the regulation of alveolar repair processes.
Background
Extensive damage and remodelling of the alveolar epi-
thelium occur in various lung pathologies, including
acute lung injury (ALI) and its more severe form, acute
respiratory distress syndrome (ARDS) [1–3]. Alveolar re-
generation, which is crucial to restore alveolar epithelial
integrity and function, is thus a critical component of
ARDS resolution and patient recovery [1, 2, 4].
After damage, several cellular events are engaged in an
attempt to restore alveolar integrity, including changes
in cell-matrix adhesion through the action of matrix
metalloproteinases and integrin receptors, cytoskeleton
reorganization, cell spreading and migration, as well
as cell proliferation and differentiation [5]. These
complex processes integrate multiple mechanisms
and proteins, which are regulated by various compo-
nents such as growth factors, growth factor receptors
and downstream signalling pathways [5–7]. Integrins
play an active role in epithelial repair, not only by
creating a link between the ECM and cell cytoskel-
eton but also by interacting with proteins involved in
cell migration and proliferation, including growth fac-
tor receptors, protein kinases as well as ion channels [8–
11]. β1-integrin, for example, has been shown to regulate
alveolar type II (ATII) cell migration on fibronectin matrix
[12]. Moreover, increased levels of fibronectin and colla-
gen have been detected in lung tissues from patients with
ARDS [13].
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Increasing evidence also indicates a function of potas-
sium (K+) channels in the regulation of epithelial repair
processes [14]. More precisely, silencing or inhibition
of different types of K+ channels has been reported to
decrease epithelial cell proliferation [15–18], motility
[15, 16, 19–23] and differentiation [20], as well as epithelial
wound repair [15, 16, 24–26]. Our data on primary rat ATII
cells previously highlighted an involvement of two types of
K+ channels, i.e. KvLQT1 and KATP, in the control of cell
proliferation, motility and repair [15]. A role for KCa3.1
channels in airway ion transport [27, 28], as well as repair
processes of several epithelial tissues [16, 22, 29] has also
been established; however, the contribution of this channel
in alveolar repair has not been explored before.
The mechanisms whereby K+ channels control epithe-
lial repair processes may be multiple, including changes
in membrane potential, cell volume and shape, [Ca2+]i
and various signalling pathways (for review see [14]). In
addition, several reports indicated that different types of
K+ channels (e.g. BKCa, Kv1.3, hERG, GIRK, Kir4.2)
could also directly interact with migratory machinery
proteins, such as β1-integrins [30–33]. However, to the
best of our knowledge, a relationship between the
KCa3.1 and β1-integrin in epithelial cells has never been
investigated before.
Based on these data, we postulated that KCa3.1 and β1-
integrin play a complementary role during alveolar epithe-
lial repair. We thus evaluated the roles of extracellular
fibronectin matrix, β1-integrin and KCa3.1 channels in
alveolar repair processes, especially cell migration, prolif-
eration and wound healing after mechanical injury. Finally,
the regulation and complementary function of TRPC4 Ca2
+ channels were explored.
Methods
Alveolar epithelial type II cell isolation and primary
culture
Alveolar epithelial cells were isolated from rat lungs
according to a procedure approved by our institutional
animal care committee (CIPA) of Centre de Recherche
du Centre Hospitalier de l’Université de Montréal
(CRCHUM) in accordance with the Canadian Council of
Animal Care (CCAC) standards. Alveolar epithelial type
II (ATII) cells were isolated from adult male Sprague–
Dawley rats (6–7 weeks), according to a well-established
protocol [15, 34–36]. In brief, the lungs were washed to
remove blood cells and alveolar macrophages before
treatment with elastase (Worthington, Lakewood, NJ,
USA). They were then minced, and the resulting suspen-
sion was filtered. Alveolar cells were collected and
purified using a differential adherence technique [37],
which enhances the purity of the ATII cell pool up to
86 % [35, 38]. Although most of the macrophages are
bound on IgG coated plates during this differential
adherence technique, some retained in the final post-IgG
cell mix (along with some red blood cells), where they likely
constituted a significant proportion of non-alveolar cells in
the cell prep at day 0 [38]. This freshly isolated cell suspen-
sion was seeded on Petri dishes (Corning, Fisher Scientific
Ltd., Nepean, ON, Canada) or on glass slides (VWR Inter-
national, Mississauga, ON, Canada) and adherent alveolar
epithelial cells were cultured in minimal essential medium
(MEM; Gibco, Life Technologies Inc., Burlington, ON,
Canada) containing 10 % FBS (Gibco, Life Technologies
Inc.), 0.08 mg/l gentamicin, septra (3 μg/ml trimetho-
prime + 17 μg/ml sulfamethoxazole), 0.2 % NaHCO3
(Sigma-Aldrich, Oakville, ON, Canada), 10 mM HEPES
(Hyclone, Fisher Scientific Ltd.), and 2 mM L-glutamine
(Gibco, Life Technologies Inc.), as previously described
[15, 35]. The MEM-FBS-septra medium was replaced after
3 days by the same MEM-FBS without septra.
Wound-healing assay
ATII cells, cultured for 3–4 days, were injured mechanic-
ally with a pipette tip (six wounds per Petri dish) accord-
ing to a highly reproducible technique [15, 16, 39–42].
This commonly employed “wound-healing assay” allows
for the study of early mechanisms engaged after injury, i.e.
cell migration and proliferation [39]. A mark on the Petri
dishes enabled us to photograph the wounds at exactly the
same place at various times (at time 0 after injury and after
24 h of repair). The rate of wound closure, presented in
μm2/h, was calculated with ImageJ software (National In-
stitutes of Health, Bethesda, MD, USA) from the wound
area measured after repair compared with the initial
wound area, for each wound.
Proliferation assay
ATII cells were seeded at low density (52,000/cm2) in 35-
mm Petri dishes for 3 days in MEM-FBS-septra medium
and then exposed or not to TRAM-34 (Sigma-Aldrich) for
a 24-h period. Cell growth was evaluated by counting the
number of ATII cells by separation with trypsin-EDTA
(0.05 %, Gibco, Life Technologies Inc.) before (at day 3,
T0) and after (at day 4, T24h) treatment. The absence of
drug cytotoxicity was verified by trypan-blue exclusion
assay. The number of ATII cells was also counted at day 3
after transfection with negative control or KCa3.1 siRNAs
(see section on siRNA transfection).
Cell migration assays
ATII cell migration was first evaluated by Boyden-type
chamber assays, as previously described [15, 39]. Briefly,
primary ATII cells were separated with trypsin-EDTA
(Gibco, Life Technologies Inc.), counted, and their viability
was verified with Trypan blue assay (Sigma-Aldrich). A
series of experiments was also performed on ATII cells
previously transfected with negative control or KCa3.1
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siRNAs (see section on siRNA transfection). The cell sus-
pensions (75,000 cells in FBS-free MEM) were placed in
the upper compartment of 8-μm pore filters (0.33 cm2,
ThinCerts-TC inserts, Greiner Bio-one; MJS Biolynx,
Brockville, ON, Canada) coated on the lower side with a
gelatin (control condition, Sigma-Aldrich) or fibronectin
matrix (Sigma-Aldrich). The lower compartment was filled
with FBS-free MEM in the absence or presence of TRAM-
34. After an 18-h migration period, the filters were washed
with PBS, the cells were fixed with paraformaldehyde-
acetone solution and then stained with hematoxylin
(Sigma-Aldrich). Non-migrating cells in the upper com-
partment were scraped off with cotton-tipped applicators
(Fisher Scientific Ltd.), whereas migrating cells on the lower
face of the filters were counted in different randomly
chosen fields under a light-inverted microscope at x20 mag-
nification. Two-D cell migration rates (μm/h) of single cells
were also evaluated by single-cell tracking in live-video
microscopy experiments. Images were captured at 5-min
intervals over a 24-h period by digital camera connected to
Zeiss microscope. The migration rates and cell trajectories
were analyzed by AxioVision software (Carl Zeiss, Jena,
Germany).
Immunoblotting of enriched ATII membrane fractions and
co-immunoprecipitation of KCa3.1 and ß1-integrin
For enriched membrane fraction assays, ATII cells were
scraped into TRIS-sucrose buffer (20 mM TRIS HCl
(Life Technologies Inc.), 5 mM EDTA (ACP, Montréal,
QC, Canada), 200 mM sucrose (Sigma-Aldrich), protease
inhibitor cocktail (Complete Mini EDTA-free protease
inhibitor cocktail, Roche Applied Science, Laval, QC,
Canada)) and then homogenized with a glass putter for
1 min. Cell lysates were centrifuged 15 min at 3,000 rpm
(4 °C), supernatants were collected and then centrifuged
at 38,000 rpm for 1 h30 at 4 °C. Supernatants were har-
vested and enriched membrane fractions in pellet were
resuspended in lysis buffer (150 mM NaCl (ACP), 50 mM
Tris–HCl, pH 7.6, 1 % Triton X-100 (Fisher Scientific
Ltd.), 0.1 % SDS (Bioshop Canada Inc., Burlington, ON,
Canada), protease inhibitor cocktail). Protein concentra-
tions were then measured by Bradford assay and immuno-
blotting was conducted as described below.
For co-immunoprecipitation assays, ATII cell lysis was
performed in buffer 1 (150 mM NaCl, 50 mM Tris–HCl,
pH 7.5, 1 % Nonidet P40, and 0.5 % sodium deoxycho-
late) from the immunoprecipitation kit (protein A,
Roche Applied Science) following the manufacturer’s in-
structions. The lysates were homogenized and isolated
by centrifugation. After quantification using the Brad-
ford method, 1–2 mg proteins from the soluble lysate
were precleared with 50 μl of 50 % protein A-agarose
suspension. The precleared soluble lysates were then in-
cubated for 1–2 h with a rabbit anti-KCa3.1 antibody
(APC-064, Alomone Labs, Jerusalem, Israel) [43] or a
mouse anti-β1-integrin antibody (610467, BD Biosci-
ences, Mississauga, ON, Canada). The immunocom-
plexes were precipitated by overnight incubation at 4 °C
with 50 μl of 50 % protein A-agarose suspension. After
being washed twice with both buffer 1 (see composition
above) and buffer 2 (500 mM NaCl, 50 mM Tris–HCl,
pH 7.5, 0.1 % Nonidet P40, 0.05 % sodium deoxycholate)
and then once with buffer 3 (10 mM Tris · HCl, pH 7.5,
0.1 % Nonidet P40, 0.05 % sodium deoxycholate), pro-
teins bound to beads were collected by centrifugation
and eluted by 30–50 μl of 2X sample buffer (62.5 mM
Tris–HCl, pH 6.8, 2 % SDS, 10 % glycerol, 0.2 % bromo-
phenol blue, 4 % β-mercaptoethanol). Control assays, in
the absence of lysate or antibodies during IP, have also
been performed.
Enriched membrane fraction proteins and immunopreci-
pitated proteins were then separated by SDS-PAGE and
transferred onto nitrocellulose membranes (GE Healthcare,
Mississauga, ON, Canada) according to a well-established
laboratory protocol [15, 36]. After blocking, the membranes
were incubated with anti-KCa3.1 (APC-064, Alomone
Labs), anti-β1-integrin (610467, BD Biosciences) or anti-
TRPC4 (ACC-018, Alomone Labs) antibodies. After wash-
ing, the membranes were incubated with goat anti-rabbit
(for KCa3.1 and TRPC4, Cell Signaling Technology,
Danvers, MA, USA) and goat anti-mouse (for β1-
integrin, Millipore, Etobicoke, ON, Canada) IgG linked
to horseradish peroxidase for 1 h. The intensity of each
specific band was quantified with ChemiDoc XRS+ Mo-
lecular Imager and Image Lab software (Bio-Rad, Mis-
sissauga, ON, Canada).
Immunofluorescence assay
ATII cells were seeded at low confluency on glass cover-
slips. On day 3, cells were fixed in 4 % paraformaldehyde
(Electron Microscopy Sciences, Hatfield, PA, USA) in
PBS for 20 min and permeabilized with 0.1 % triton
X100 in PBS for 10 min at room temperature. After
blocking in PBS containing 5 % bovine serum albumin
(Fisher Scientific Ltd.) for 1 h30, cells were incubated
with specific anti-KCa3.1 and β1-integrin antibodies for
1 h30. Absence of background signal and non-specific
staining was verified in control experiments, by omitting
primary antibodies. Cells were then incubated with anti-
rabbit-CF633 (Sigma-Aldrich, for KCa3.1 detection) or
Alexa Fluor 488-conjugated anti-mouse (Life Technolo-
gies Inc., for β1-integrin detection) antibodies for
45 min. Slides were finally rinsed and counterstained
with DAPI (Sigma-Aldrich). Fluorescent images were
captured with an ExiAqua camera (QImaging, Surrey,
BC, Canada) connected to an Olympus fluorescence
microscope (Olympus, Richmond Hill, ON, Canada).
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Small interfering (si)RNA transfections
After isolation, ATII cells in suspension were transfected
with a combination of Lipofectamine™ RNAiMAX (Invi-
trogen) and Universal negative control or KCa3.1 siR-
NAs (Sigma-Aldrich). Five h after seeding, fresh
complete MEM was added onto cells, which were then
primary cultured for 3 to 4 days. Efficient transfection
(>80 %) was observed in these conditions and KCa3.1 si-
lencing (>70 %) was verified by PCR (see below).
PCR amplifications
Five μg of total RNA purified from ATII cells with TRI-
zol reagent (Life Technologies Inc.) was reverse-
transcribed into cDNA with MMLV reverse transcriptase
(RT, Life Technologies Inc.) in the presence of oligodT
primers (Invitrogen, Life Technologies Inc.). cDNAs
were amplified with Taq polymerase (Life Technologies
Inc.) and specific primers designed from sequences of
rat KCa3.1 and TRPC channels: KCa3.1 5′-gctgttcatgact
gacaacg-3′ and 5′-catagccaatggtcaggaac-3′, 500-bp pro
duct; TRPC1 5′- gattttgggaaatttctaggaatg-3′ and 5′-ctcat
gatttgctatcagctgg-3′, 363-bp product; TRPC2 5′- cgttcca
gtttctcttctggaccat-3′ and 5′- agcatcgtcctcgatcttctgg-3′, 1
91-bp product; TRPC3 5′- tgatgaggtgaacgaaggtgaactg-3′
and 5′- tgcccacatttgtgccagagtca-3′, 206-bp product; TR
PC4 5′- tctgcagatatctctgggaaggatgc-3′ and 5′- aagctttgtt
cgagcaaatttccattc-3′, 415-bp product; TRPC5 5′- cccgg
catgaattcacggag-3′ and 5′- catggtcggcaatgagctggtag-3′,
129-bp product; TRPC6 5′- gagaacataggctatgttctgtatggag
tc-3′ and 5′- gccatcatcctcaatttcctgg-3′, 114-bp product;
TRPC7 5′- tccctttaacctggtgccgagtc-3′ and 5′- ttcagcatg
cccatttccagg-3′, 129-bp product. Primer pairs were de-
signed in distinct exons to avoid genomic DNA amplifi-
cation. RT-PCR amplification was undertaken according
to a well-established laboratory protocol [35, 36, 44].
PCR products were normalized with the β-actin signal
for each cDNA sample (β-actin 5′-ctaaggccaaccgt-
gaaaag-3′ and 5′- gccatctcttgctcgaagtc-3′, 311-bp prod-
uct). The RT-PCR products were finally separated on
agarose gels, stained with SYBR Safe (Life Technologies
Inc.). Signals were detected by Typhoon Gel Imager and
analyzed by ImageQuant software (Molecular Dynamics,
Baie d’Urfé, QC, Canada) [35, 36, 44].
Fura-2 calcium imaging
Intracellular calcium concentration ([Ca2+]i) was moni-
tored using the fluorescent dye Fura-2. Briefly, ATII cells
cultured on coverslips were loaded (1 h15 at 37 °C) with
5 μM Fura-2-AM (Life Technologies Inc.) in MEM con-
taining 0.04 % pluronic F127 (Life technologies Inc.)
followed by a 45 min de-esterification in MEM. Cover-
slips with loaded cells were then mounted in the im-
aging chamber on the stage of an inverted microscope
(Nikon TE300, Mississauga, ON, Canada) and bathed
with a physiological saline solution (PSS, 140 mM
NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 11.1 mM
glucose, 10 mM HEPES, pH 7.4). To measure the Ca2+
permeability through ATII cell plasma membranes, PSS
was replaced by the same solution without Ca2+ and
supplemented with 1 mM EGTA (PSS 0 Ca2+). Cells
were then alternately excited at 340 and 380 nm with a
high-pressure mercury lamp via interference filters
(Chroma Technology, Brattleboro, VT, USA) mounted
on a filter wheel (Sutter Lamba 10-C, Sutter Instrument,
Novato, CA, USA) with a dichroic mirror (510/540 nm,
Chroma Technology). Fluorescence images were recorded
at 5-s intervals by digital camera using Metafluor software
(Molecular Devices, Guelph, ON, Canada) and analyzed
with Metafluor Analysis (Molecular Devices). Fura-2
fluorescence measurements (corresponding to the mean
fluorescence values of 30 cells/field) are presented as
[Ca2+]i, which was calculated accordingly to the Gryn-
kiewicz equation [45], using a Kd of 225 nM. Rmax was
determined by the addition of digitonin (4 μM, Sigma-
Aldrich) to PSS (2 mM Ca2+) and Rmin by subsequent
addition of ethylene glycol-bis ([β-amino-ethyl ether)-
N,N,N’,N’-tetraacetic acid (EGTA) at a final concentra-
tion of 20 mM.
Statistical analysis
The data are presented as mean ± standard error of the
mean (SEM). Statistical analyses were performed with
GraphPad Prism version 5 for Windows (GraphPad soft-
ware, San Diego, CA, USA) using Wilcoxon signed rank
test and one sample sign test. Two-way Anova tests were
performed with IBM SPSS Statistics 22 (IBM Corp.,
Armonk, NY). Differences were considered significant
when p < 0.05.
Results
Involvement of KCa3.1 in ATII epithelial repair on
fibronectin matrix
A well-established wound-healing assay with mechanical
injury of primary ATII cell monolayers was used to
study the contribution of KCa3.1 channels in the healing
process. We first observed that the presence of TRAM-
34 (5 and 10 μM), a specific KCa3.1 inhibitor, did not
affect the wound-healing rates of ATII cell monolayers
in the absence of coating (Fig. 1b). In agreement with
data from the literature [12], we then confirmed that the
wound-closure rates of ATII cell monolayers grown on a
fibronectin matrix were higher (38.3 ± 3.0 × 103 μm2/h)
compared to cells cultured in the absence of matrix
(30.5 ± 3.1 × 103 μm2/h), i.e. an increase of 7.8 × 103 μm2/h
(p < 0.04, Fig. 1a and b). This stimulatory effect was par-
tially prevented by an anti-β1-integrin antibody (decrease
of 3.5 × 103 μm2/h, p < 0.02, not shown).
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We also observed a dose-dependent reduction of
fibronectin-stimulated wound-healing rates after KCa3.1
inhibition (15 and 33 % inhibition in the presence of 5
and 10 μM TRAM-34 respectively, Fig. 1b). In a previ-
ous study [15], we demonstrated an involvement of two
other types of K+ channels, i.e. KvLQT1 and KATP, dur-
ing alveolar repair which did not required fibronectin
coating. We now verified that the wound healing rate on
fibronectin coating (47.0 ± 3.8 × 103 μm2/h) was also sig-
nificantly reduced in the presence of KvLQT1 and KATP
inhibitors (i.e., clofilium (5 μM) and glibenclamide
(10 μM), 32.1 ± 5.0 × 103 μm2/h, p < 0.04, not shown).
Moreover, the combination of TRAM-34 (20 μM), with
clofilium and glibenclamide, elicited an additional inhibi-
tory effect of the repair rates on fibronectin (24.4 ± 4.4 ×
103 μm2/h, p < 0.04, not shown).
Our data point to an involvement of KCa3.1 channels
in the regulation of ATII wound repair in the presence
of a fibronectin matrix. We then undertook complemen-
tary experiments to further assess the role of KCa3.1 in
two crucial processes of epithelial repair, i.e. cell prolifer-
ation and migration.
Impact of KCa3.1 inhibition on ATII cell growth
ATII cell growth was evaluated by counting the number
of cells at day 3 and 4 in subconfluent primary cultures,
Fig. 1 Impact of KCa3.1 inhibition on fibronectin-stimulated ATII wound repair. ATII cell monolayers, grown in the absence (no coating) or
presence of fibronectin coating, were injured mechanically and wound-healing rates were measured over a 24-h period, in the presence or
absence of the KCa3.1 inhibitor TRAM-34. Representative photographs (x4 magnification) at time 0 (T0) and 24 h (T24) after injury in each condition
are presented in (a). The wound edge is indicated by the dotted lines. b. Mean wound-closure rates (μm2/h) are compared in control (0) and
TRAM-34 (5 and 10 μM) treated monolayers, in the absence or presence of fibronectin coating (n = 6). *p < 0.05
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exposed to 5, 10 and 20 μM TRAM-34 over the 24-h
period (day 3 to day 4). Similar to wound-healing as-
says, we observed that ATII cell growth was not af-
fected by KCa3.1 inhibition with TRAM-34 in the
absence of fibronectin coating (Fig. 2a). However,
TRAM-34 significantly decreased the growth of ATII
cells cultured on fibronectin matrix (19, 17 and 24 %
reduction in presence of 5, 10 and 20 μM TRAM-34 re-
spectively, Fig. 2b).
Involvement of KCa3.1 in ATII cell motility
The role of KCa3.1 in ATII cell motility was assessed
using two complementary approaches. Boyden-type
chamber assays first showed that TRAM-34 exposure
did not decrease the number of migrating cells in con-
trol conditions (absence of fibronectin matrix) (Fig. 3a,
left panel), whereas fibronectin-stimulated cell migration
was significantly reduced by TRAM-34 (12, 19 and 23 %
inhibition in the presence of 5, 10 and 20 μM TRAM-34
respectively, Fig. 3a, right panel). The involvement of
KCa3.1 in 2D cell migration dynamics was then assessed
by single-cell tracking in subconfluent ATII cell cultures
using time-lapse video-microscopy experiments. As
depicted in Fig. 3b, TRAM-34 did not impact ATII cell
trajectories and migration rates in the absence of coating
(left panels, no coating). On the contrary, ATII cell tra-
jectories on fibronectin matrix were altered by TRAM-
34 and the mean migration rate (37 μm/h in absence of
TRAM-34) was decreased to 31, 25 and 24 μm/h in the
presence of 5, 10 and 20 μM TRAM-34, respectively
(Fig. 3b, right panels). These results demonstrated a cru-
cial role of KCa3.1 channels in the control of ATII cell
motility on fibronectin.
Impact of KCa3.1 silencing on wound healing, cell
proliferation and migration
To confirm the role of KCa3.1, we then adopted a com-
plementary approach with specific KCa3.1 siRNAs. After
verification of siRNA efficiency (Fig. 4a), we showed that
KCa3.1 down-regulation did not reduced alveolar repair
in the absence of coating (Fig. 4b, left), whereas it was
associated with a significant decrease in wound-healing
(28.8 ± 2.3x103 μm2/h in the presence of KCa3.1 siRNA),
compared to ATII cells exposed to negative control
siRNA (33.9 ± 1.7x103 μm2/h, P < 0.05, Fig. 4b, right) on
fibronectin coating. The number of ATII cells at day 3
after transfection with negative control and KCa3.1 siR-
NAs was similar in non-coated conditions, whereas a
small, non-significant decrease in cell proliferation was
noted on fibronectin coating in the presence of KCa3.1
siRNA (Fig. 4c). We also observed that the number of
migrating cells through a Boyden type chamber was sig-
nificantly reduced after KCa3.1 silencing (siKCa3.1) in
the presence of fibronectin, but not in the absence of
matrix (Fig. 4d).
Wound healing stimulation by KCa3.1 activation
Because our data with TRAM-34 and siRNA indicated
that alveolar wound repair on fibronectin matrix is, at
least in part, dependent on KCa3.1 function, we next ex-
plored a potential beneficial impact of KCa3.1 activation
on ATII wound-healing. As presented in Fig. 5, the re-
pair rates of ATII cell monolayers grown in the absence
of coating (30 ± 2 × 103 μm2/h) were stimulated by in-
creasing concentrations of 1-EBIO. This KCa activator
also enhanced the fibronectin-stimulated wound repair,
reaching a rate of 42 ± 3 × 103 μm2/h in the presence of
coating and 200 μM 1-EBIO.
Fig. 2 Involvement of KCa3.1 channels in ATII cell proliferation. Subconfluent ATII cells grown for 3 days in the absence (a) or presence of
fibronectin coating (b) were exposed to increasing TRAM-34 concentrations (5, 10 or 20 μM) for 24 h. Cell proliferation was estimated at day 3
(T0, before treatment) and day 4 (T24h) in each condition. (n = 8). *p < 0.05
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Relationship between KCa3.1 channels and β1-integrin
Based on our data indicating a cooperative role played
by KCa3.1 and fibronectin matrix in alveolar wound
repair, we then decided to further investigate a pos-
sible relationship between the KCa3.1 channel and the
β1-integrin, a receptor and signal transducer of fibro-
nectin [12].
We first explored a possible spatial co-distribution of
KCa3.1 channel and β-1 integrin. As shown in Fig. 6a,
both KCa3.1 and β1-integrin proteins were detected by
immunofluorescence assays in ATII cells. More import-
antly, these two proteins were predominantly co-
distributed at the plasma membrane (Fig. 6a, top merge
panel). It should be noted that there was no, or very dif-
fuse, signal with secondary antibodies in control experi-
ments in the absence of respective primary antibodies
(Fig. 6a, negative controls).
We then assessed a possible assembly of these two
proteins using co-immunoprecipitation assays. Expres-
sion of β1-integrin and KCa3.1 proteins was first con-
firmed by western blotting on ATII cell extracts
(Fig. 6b, lane 1, « total lysate »), where doublets of
120–105 (mature and immature β1-integrin proteins,
IB: β1-integrin) and 51 kDa (IB: KCa3.1) bands were
detected using anti-β1-integrin and anti-KCa3.1 anti-
bodies, respectively. Interestingly, KCa3.1 proteins was
Fig. 3 Impact of KCa3.1 inhibition on ATII cell motility. ATII cell migration was evaluated using Boyden-type assays (a) and single cell tracking in
live time-lapse videomicroscopy (b). The number of migrating ATII cells were measured over an 18-h period in the absence (0) or presence of 5,
10 or 20 μM TRAM-34 and compared in the absence (a, no fibronectin coating, left panel) or presence of fibronectin (a, right panel) (5 fields/
insert, 3 inserts/condition, n = 4-6). 2D cell migration rates (b) were evaluated by ATII single-cell tracking (~15 cells/field, 2 fields/condition/
experiment, n = 6) over a 24-h period in the absence (0) or presence of TRAM-34 (5, 10 and 20 μM). Representative trajectories of ATII cells in the
absence or presence of a fibronectin matrix, in control condition and in the presence of 20 μM TRAM-34 are presented in the top panel (b).
Colors indicate 0-h (blue) to 24-h (red) time points. *p < 0.05
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also detected after immunoprecipitation (IP) using
anti-β1-integrin antibody (Fig. 6b, lane 2, « β1-integrin
IP », IB: KCa3.1). We also detected β1-integrin pro-
teins, after KCa3.1 immunoprecipitation (Fig. 6b, lane
3, « KCa3.1 IP », IB: β-integrin). This result thus
showed for the first time that KCa3.1 could form an
immunoprecipitable complex with the β-1 integrin in
the ATII cells.
The expression levels of KCa3.1 and β1-integrin pro-
teins in enriched membrane fractions of ATII cells were
then compared in the presence or absence of fibronectin
coating. We noted that ATII cells grown in the presence
of fibronectin matrix expressed a higher level of the
KCa3.1 and β1-integrin proteins in their membrane
fractions (~50 % and 80 % enhancement, respectively)
compared to cells cultured in the absence of coating
(Fig. 6c). This observation reinforced the hypothesis of a
relationship between β1-integrin and KCa3.1.
Involvement of calcium transport in fibronectin-
stimulated ATII wound repair
The involvement of KCa3.1, which is a calcium-activated
potassium channel [46], during ATII wound repair on
fibronectin, suggested that changes in intracellular cal-
cium may occur in these conditions. We first evaluated
the variation in [Ca2+]i using Fura-2 assays in the pres-
ence and absence of fibronectin coating. We first noted
that the steady-state [Ca2+]i was higher (78.8 ± 8.8 nM)
Fig. 4 Delayed ATII wound repair and reduced cell proliferation and migration after KCa3.1 silencing in the presence of fibronectin coating. ATII
cells were transfected with negative control siRNA (siRNA control) or siRNAs directed against KCa3.1 (siKCa3.1) and then seeded in the absence or
presence of fibronectin coating. KCa3.1 silencing was verified by PCR (a, n = 7). A representative agarose gel is presented on the left. (b)
Wound-healing rates (in μm2/h) were measured at 24 h after injury among cells transfected with control or KCa3.1 siRNAs in the absence of
coating (left) and in the presence of fibronectin matrix (right) (n = 7). The number of ATII cells was counted at day 3 of culture after transfection
with control or KCa3.1 siRNAs (n = 14, c). The number of migrating ATII cells, transfected 3 days before with control or KCa3.1 siRNAs, was
measured in a Boyden type chamber over an 18-h period in the absence (no coating) or presence of fibronectin (n = 6, d). *p < 0.05
Girault et al. Respiratory Research  (2015) 16:100 Page 8 of 15
in ATII cells cultured on fibronectin compared to the
control condition (absence of coating, 53.8 ± 4.3 nM,
Fig. 7a). The plasma membrane Ca2+ permeability of
ATII cells was also estimated by replacing the saline so-
lution bathing the cells, which contained 2 mM Ca2+, by
a Ca2+ free saline solution supplemented with 1 mM
EGTA. This extracellular Ca2+ removal was followed by
a reduction in [Ca2+]i level of 30.3 ± 3.1 nM in absence
of coating. Notably, the change in [Ca2+]i was higher
(43.8 ± 5.1 nM) in the presence of fibronectin (Fig. 7b).
Because calcium membrane transport mechanisms in
ATII cells are not well defined, we decided to investigate
the identity of Ca2+ channels that could be involved in
the observed modifications in Ca2+ levels in cell grown
on fibronectin. We focused on a subgroup of the large
TRP channel family, the TRPC channels [47, 48], be-
cause at least one member of this subfamily has already
been proposed as a functional partner of KCa3.1 [49].
Using RT-PCR, we detected the mRNA expression of
all seven members of the TRPC family (TRPC1 to
TRPC7, Fig. 8a). As shown in Fig. 8b, a huge enhance-
ment in TRPC4 mRNA expression was observed in
ATII cells cultured on fibronectin matrix (compared to
the control, non-coated condition), whereas the in-
crease in TRPC2, 3 and 5 mRNA was non-significant.
Similar to KCa3.1 and β1-integrin proteins, we also
measured an enhancement of the relative level of the
TRPC4 protein expressed in the enriched membrane
fraction in ATII cells cultured on fibronectin (com-
pared to no coating, Fig. 8c).
A final series of experiments was undertaken to exam-
ine the involvement of TRPC4 channels, using the spe-
cific inhibitor ML-204 [50], in fibronectin-stimulated
alveolar wound repair. As previously observed after
KCa3.1 inhibition with TRAM-34 (Fig. 1b), blocking of
TRPC4 channels with ML-204 (Fig. 8d, ML-204) did not
significantly reduce the wound-healing rates of ATII
monolayers in the absence of coating, whereas ML-204
significantly decreased the rates on fibronectin matrix
(fibronectin +ML-204). Finally, an additive inhibitory ef-
fect of TRAM-34 on wound-healing rates was observed,
suggesting a complementary role played by KCa3.1 and
TRPC4 channels during ATII epithelial repair on fibro-
nectin (Fig. 8d, fibronectine +ML-204 + TRAM-34).
Discussion
Our study revealed that Ca2+-activated KCa3.1 channels
and interactions with integrin receptor and extracellular
matrix component (fibronectin) play a significant role in
alveolar wound repair processes. Specifically, we highlighted
a relationship between β1-integrin, a fibronectin receptor
and signal transducer, and KCa3.1 channels. We also found
that the presence of a fibronectin coating is associated with
elevated steady state [Ca2+]i as well as β1-integrin, KCa3.1
and TRPC4 channel membrane expression. Finally, our
data indicate complementary roles of ECM, β1-integrin,
KCa3.1 and TRPC4 channels during alveolar repair pro-
cesses (recapitulative scheme presented in Fig. 9).
The observed increases in ATII wound-healing (Fig. 1)
and cell migration (Fig. 3) rates on fibronectin confirm
importance of this extracellular matrix component in al-
veolar repair, in agreement with previous studies. Indeed,
Kim et al. demonstrated using Boyden chamber assays
that alveolar epithelial cell migration was increased in
the presence of either soluble or coated fibronectin [12].
A role for this extracellular matrix component has also
Fig. 5 ATII wound repair stimulation with 1-EBIO. ATII cell monolayers
grown for 3 days in the absence or presence of fibronectin coating
were treated with increasing 1-EBIO concentrations (50, 100 and
200 μM) before wounding and wound-repair rates (in μm2/h) were
measured over a 24-h period (n = 7). Representative photographs
(x4 magnification) at time 0 (T0) and 24 h (T24) after injury in the
presence or absence of 100 μM 1-EBIO are presented in the upper
panel.* p < 0.05. Two-way Anova statistical analysis revealed that both
the coating (p = 0.01) and 1-EBIO (p = 0.007) elicited a significant effect
on the wound repair rates. Moreover, the values of the fibronectin
group (1-EBIO (0, 50, 100, 200 μM) + fibronectin) were statistically
higher than the values of the uncoated group (1-EBIO (0, 50, 100,
200 μM), no coating)
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been shown in other epithelial tissues, including in the
cornea [51].
One of our previous studies [15] demonstrated that
KvLQT1 and KATP channels actively participate in the
control of ATII wound healing in the absence of
fibronectin coating, whereas our present data (Figs. 1
and 4b) indicate that KCa3.1 did not affect the wound
repair rates in these conditions. Interestingly, both
KCa3.1 pharmacological inhibition and molecular silen-
cing impaired fibronectin-stimulated ATII wound-repair
Fig. 6 Cellular co-distribution, co-immunoprecipitation and membrane expression of β1-integrin and KCa3.1 channels. a. Representative
immunofluorescence images of KCa3.1 and β1-integrin staining performed on ATII cells using anti-KCa3.1, anti-β1-integrin, anti-rabbit 633 (for
KCa3.1 detection) and anti-mouse 488 (for β1-integrin detection) antibodies. Color superposition shows similar cellular distribution of KCa3.1
and β1-integrin in ATII cells (merge panel, Scale bars, 10 μm). No or diffuse signal was detected with the Alexa fluor 488 and Alexa fluor 633
coupled secondary antibodies in control experiments (negative controls). b. Representative immunoblots showing β1-integrin and KCa3.1
co-immunoprecipitations. β1-integrin (upper panels, IB: β1-integrin) and KCa3.1 (lower panels, IB: KCa3.1) proteins were revealed with specific
antibodies after β1-integrin and KCa3.1 immunoprecipitation with anti-β1-integrin (lane 2 « β1-integrin IP ») or anti-KCa3.1 (lane 3 « KCa3.1 IP
») antibodies in ATII cell extracts. Endogenous expression of β1-integrin and KCa3.1 proteins in ATII cell lysate is also shown in lane 1, « Total
Lysate ». Lanes 4 and 5 are negative control assays showing an absence of band in IB (IB β1-integrin and IB KCa3.1) after IP in the absence of
lysate (lane 4, « Negative IP Control (no lysate) ») and in the absence of β-integrin and KCa3.1 antibodies (lane 5, « Negative IP control (no
antibody) »). c. The level of β1-integrin and KCa3.1 channel expression in membrane fractions were determined by immunoblotting using
anti-β1-integrin and anti-KCa3.1 antibodies. A representative immunoblot is shown in the left panel. The band intensities were compared in
control condition (no coating, −) and in the presence of a fibronectin (+) matrix (right panel, n = 11). *p < 0.05
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rates (Figs. 1 and 4b). This discrepancy could be ex-
plained by variable basal activity of KvLQT1, KATP and
KCa3.1 channels in ATII cells. Indeed, it is possible that
KCa3.1 channels require a signal, through β1-integrin
activation in presence of fibronectin, to participate in
ATII wound-healing processes, whereas KvLQT1 and
KATP channels may exhibit sufficient basal activity to
regulate alveolar epithelial repair even in absence of
coating. In agreement with this hypothesis our data indi-
cated an additive effect after concomitant inhibition of
KvLQT1, KATP and KCa3.1 channels on fibronectin
matrix. It could also be postulated that the TRAM-34-
sensitivity on fibronectin coating could be due to the ob-
served increased expression (Fig. 6c) of KCa3.1/integrin
proteins, which cooperate to regulate alveolar repair,
migration and proliferation in this condition. A role for
KCa3.1 channels in the control of both ATII cell prolifera-
tion and migration on fibronectin (Fig. 4) was also con-
firmed by the siRNA approach. Such an involvement of
KCa3.1 in cell motility [52–55] or proliferation [56, 57]
had previously been established in other cell types.
The observation that KCa3.1 function in alveolar repair is
dependent on the presence of fibronectin suggests a poten-
tial link between KCa3.1 and extracellular matrix receptors,
such as integrins. In agreement with this hypothesis, our
immunofluorescence and co-immunoprecipation experi-
ments (Fig. 6) demonstrate for the first time a cellular co-
distribution and a potential physical link between KCa3.1
and β1-integrin in ATII cells. Although such observations
have never been reported before in native epithelial cells,
Fig. 7 Impact of fibronectin coating on calcium signal in ATII cells. a. [Ca2+]i was measured using Fura-2 in ATII cells bathed with a physiological
saline solution containing 2 mM Ca2+ and compared in the absence (−) or presence (+) of fibronectin coating. b. Ca2+ permeability through ATII
cell membranes was evaluated after external calcium removal. Illustrative traces showing the decrease of [Ca2+]i as a function of time in absence
(no coating) or in presence of fibronectin matrix (fibronectin) after PSS 0 Ca2+ application are presented on top panels (b). The mean amplitudes
of [Ca2+]i decrease were compared in the absence or in presence of fibronectin matrix (bottom panel, b). (n = 10) *p < 0.05
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physical or functional interactions between other types
of K+ channels (e.g. BKCa, Kv1.3, hERG, Kir4.2) and
integrins have already been reported in other cell types
[30–33]. Levite et al., for example, reported a physical
association between Kv1.3 channels and β1-integrin, de-
tected by co-immunoprecipitation assays, in human T
cells [32]. The same approach was undertaken in a neuro-
blastoma cell line to identify a link between hERG1 chan-
nel and β1-integrin, which were also co-localized [30].
In the present study, we observed a significant increase
in β1-integrin and KCa3.1 expression in the membrane
fraction of ATII cells cultured on fibronectin coating
(Fig. 6c). Although our data did not allow us to define
which cellular mechanism could explain this observed
up-regulation, it has been proposed in other studies that
protein phosphorylation, Ca2+ signalling or G proteins
could be responsible for the modulation of K+ channel
properties by integrins [9, 58]. In agreement with our
results, it has been also shown that the level of hERG
channel co-immunoprecipitated with β1-integrin is in-
creased after β1-integrin activation [30].
Due to the Ca2+ sensitivity of KCa3.1 channels, the
levels of [Ca2+]i in ATII cells in the absence or presence
of a fibronectin matrix were also analyzed. Our data
showed that [Ca2+]i is significantly higher in the pres-
ence of fibronectin (Fig. 7). This result is in agreement
Fig. 8 Expression of TRPC channels in ATII cells and complementary roles of TRPC4 and KCa3.1 in wound repair on fibronectin matrix. Representative
agarose gel showing PCR products amplified from ATII cDNA with PCR primer pairs designed from rat TRPC channels (a). TRPC channel relative mRNA
expressions were normalized to β-actin and compared between no coating and fibronectin matrix conditions (b, n = 16–20). c. Levels of TRPC4 protein
expression in membrane fractions were measured by immunoblotting using specific anti-TRPC4 channel antibody and band intensities were compared
between control (no coating) and fibronectin matrix conditions (c, right panel, n = 11). A representative immunoblot is shown in the left panel. d. ATII
cells, cultured in the absence (−) or presence (+) of a fibronectin coating, were injured mechanically and the wound-healing rates (μm2/h) over a 24-h
period were then compared in control condition (−), in presence of the TRPC4 inhibitor ML-204 (100 μM, +) (n = 8) or a combination of ML-204
(100 μM) and TRAM-34 (20 μM) (d, n = 7). *p < 0.05
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with a study by Sjaastad et al., [59] showing that integrin
activation in MDCK cells, using microbeads coated with
RGD motif, was associated with [Ca2+]i increase, most
probably through a Ca2+ influx. Our Fura-2 assays also
indicated that membrane Ca2+ permeability in ATII cells
was enhanced in the presence of fibronectin. In an at-
tempt to define the identity of the membrane Ca2+ chan-
nel(s) that may be involved in that response, we decided
to focus on the TRPC family, because TRPC3 channel
has already been shown to facilitate the KCa3.1 channel
activation [49]. Although we detected all members of the
TRPC family (TRPC1-7, [47], Fig. 8) in ATII cells, only
TRPC4 mRNA expression was significantly enhanced in
the presence of fibronectin. Moreover, analysis of protein
expression in membrane fraction revealed that TRPC4
levels, similarly to KCa3.1 and β-1 integrin, were signifi-
cantly enhanced in ATII cells cultured on fibronectin
coating (Fig. 8c). The signalling pathways responsible for
TRPC4 up-regulation were not elucidated in our study;
however, it has previously been demonstrated that
TRPC4 membrane translocation was dependent of Src
phosphorylation after EGF stimulation [60]; a phosphor-
ylation pathway also known in the regulation of ion
channels by integrin [9, 58]. The relative contribution of
TRPC4, as well as other types of Ca2+ channels, includ-
ing voltage-dependent and independent Ca2+ channels
to the complex Ca2+ signal during wound repair or after
changes in integrin and K+ channel activation has not
been evaluated in that study but would deserve further
investigation.
Finally, we observed for the first time that TRPC4
channels are involved in ATII wound healing. In fact, we
measured a 3-fold stronger inhibition of ATII wound
repair rates with the TRPC4 inhibitor ML204 on the fi-
bronectin matrix than in the absence of coating. This
effect is in agreement with the observed increased TRPC
expression on fibronectin coating. Although a function
of TRPC4 channels in alveolar repair has never been
reported before, other members of the TRPC family have
already been described as regulators of cell migration in
non-tumoural cells (TRPC1 and TRPC3 in intestinal epi-
thelial cells or monocytes respectively [61, 62]) or in
lung cancer cells (TRPC1, 3, 4 and 6 [63]). Furthermore,
we observed that the combination of KCa3.1 and TRPC4
inhibitors led to an additive inhibitory effect (Fig. 8d),
suggesting that these two channels are complementary
partners in the control of ATII wound healing on
fibronectin.
As described above, our data using KCa3.1 inhibition
or silencing demonstrated that KCa3.1 may act as a
regulator of the ATII wound-healing repair in vitro.
Interestingly, we also showed that the ATII wound-
healing rates were improved in the presence of the KCa
activator 1-EBIO (Fig. 5). Based on this evidence, it may
be postulated that KCa3.1 could play an important role
in the alveolar epithelial repair after injury and may thus
be identified as a potential therapeutic target for alveolar
epithelial repair after acute lung injury in vivo. Such a
strategy remains to be further investigated, however.
Conclusion
Our data demonstrate for the first time the complemen-
tary roles of fibronectin matrix, β-1 integrin, KCa3.1 and
TRPC4 channels in the regulation of alveolar epithelial
repair processes (Fig. 9). Moreover, our study highlights
an improvement in ATII wound-healing after treatment
with 1-EBIO, suggesting use of KCa3.1 activators as po-
tential therapeutic strategy to favor the resolution of
acute lung injury in vivo.
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Fig. 9 Complementary roles of ECM, β1-integrin, KCa3.1 and TRPC4
channels during alveolar repair process. The presence of fibronectin
matrix evokes an increase in membrane expression of β1-integrin,
KCa3.1 and TRPC4, an elevation of steady-state [Ca2+]i and a stimulation
of ATII wound healing. This stimulation is dependent, at least in part on
KCa3.1 and TRPC4 channel activity. Our data also highlighted a
relationship between KCa3.1 and β1-integrin
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